Why the study?
Does the arterial occlusion technique improve the localization of increased resistance and differential diagnosis in patients with severe pulmonary hypertension?
Does the arterial occlusion technique improve the localization of increased resistance and differential diagnosis in patients with severe pulmonary hypertension?
The arterial occlusion technique can locate the predominant site of increased pulmonary resistance but does not reliably differentiate between PAH, veno-occlusive disease, and thromboembolic pulmonary hypertension on an individual basis.
Answers are grounded in this paper and cite their sources.
Arterial occlusion localizes predominant resistance site in severe PH but fails to discriminate diagnostic categories; leaves open its differential diagnostic utility.
The purpose of this study was to determine the site of increased resistance using the arterial occlusion technique in patients with severe pulmonary hypertension. Pulmonary vascular resistance was partitioned in arterial and venous components based on double exponential fitting analysis of the pulmonary artery pressure decay curve: after balloon occlusion in 36 patients with pulmonary arterial hypertension (PAH); at baseline and during the inhalation of 20 parts per million of nitric oxide (NO); in four patients with chronic thromboembolic pulmonary hypertension; and in two patients with pulmonary veno-occlusive disease. In the patients with PAH, at baseline, mean pulmonary artery pressure was 56+/-2 mmHg (mean+/-SE), with an arterial component of resistance of 63+/-1%. Inhaled NO did not change the partition of resistance. The arterial component of resistance amounted on average to 42% and 77% in the patients with veno-occlusive disease and the patients with thromboembolic pulmonary hypertension, respectively. However, the partitioning of resistance did not discriminate between these three diagnostic categories. The occlusion technique may help to locate the predominant site of increased resistance in patients with severe pulmonary hypertension, but does not allow for a satisfactory differential diagnosis on an individual basis.
No takes yet. Share an insight, caveat, or question.
Fesler et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: